Mark Obrist1, Ernest Osei-Bonsu2, Baffour Awuah3, Shinobu Watanabe-Galloway1, Sofia D Merajver4, Kendra Schmid5, Amr S Soliman6. 1. University of Nebraska Medical Center College of Public Health, Department of Epidemiology, Omaha, NE 68198, United States. 2. Komfo Anokye Teaching Hospital, Department of Medical Oncology and Radiation, Kumasi, Ghana. 3. Komfo Anokye Teaching Hospital, Central Administration, Kumasi, Ghana. 4. University of Michigan School of Public Health, Department of Epidemiology, Ann Arbor, MI 48109, United States; University of Michigan College of Medicine, Department of Internal Medicine, Ann Arbor, MI 48109, United States. 5. University of Nebraska Medical Center College of Public Health, Department of Biostatistics, Omaha, NE 68198, United States. 6. University of Nebraska Medical Center College of Public Health, Department of Epidemiology, Omaha, NE 68198, United States. Electronic address: amr.soliman@unmc.edu.
Abstract
PURPOSE: The burden of cancer in Africa is an enlarging public health challenge. Breast cancer in Ghana is the second most common cancer among Ghanaian women and the proportion of diagnosed patients who complete prescribed treatment is estimated to be very limited, thereby potentially adding to lower survival and poor quality of life after diagnosis. The objective of this study was to identify the patient and system factors related to incomplete treatment of breast cancer among patients. METHODS: This study was conducted at the Komfo Anokye Teaching Hospital in Kumasi, Ghana. We interviewed 117 breast cancer patients and next of kin of breast cancer patients diagnosed from 2008 to 2010. RESULTS: Islamic religion, seeking treatment with traditional healers, and lack of awareness about national health insurance coverage of breast cancer treatment were predictors of incomplete treatment. CONCLUSIONS: The results of this study support that Ghanaian women with diagnosed breast cancer have multiple addressable and modifiable patient factors that may deter them from completing the prescribed treatment. The results highlight the need for developing and testing specific interventions about the importance of completing treatment with a special focus on addressing religious, cultural, and system navigation barriers in developing countries.
PURPOSE: The burden of cancer in Africa is an enlarging public health challenge. Breast cancer in Ghana is the second most common cancer among Ghanaian women and the proportion of diagnosed patients who complete prescribed treatment is estimated to be very limited, thereby potentially adding to lower survival and poor quality of life after diagnosis. The objective of this study was to identify the patient and system factors related to incomplete treatment of breast cancer among patients. METHODS: This study was conducted at the Komfo Anokye Teaching Hospital in Kumasi, Ghana. We interviewed 117 breast cancerpatients and next of kin of breast cancerpatients diagnosed from 2008 to 2010. RESULTS: Islamic religion, seeking treatment with traditional healers, and lack of awareness about national health insurance coverage of breast cancer treatment were predictors of incomplete treatment. CONCLUSIONS: The results of this study support that Ghanaian women with diagnosed breast cancer have multiple addressable and modifiable patient factors that may deter them from completing the prescribed treatment. The results highlight the need for developing and testing specific interventions about the importance of completing treatment with a special focus on addressing religious, cultural, and system navigation barriers in developing countries.
Authors: Pat Fobair; Susan L Stewart; Subo Chang; Carol D'Onofrio; Priscilla J Banks; Joan R Bloom Journal: Psychooncology Date: 2006-07 Impact factor: 3.894
Authors: Kieran S O'Brien; Amr S Soliman; Baffour Awuah; Evelyn Jiggae; Ernest Osei-Bonsu; Solomon Quayson; Ernest Adjei; Silpa S Thaivalappil; Frank Abantanga; Sofia D Merajver Journal: J Registry Manag Date: 2013
Authors: Azadeh Stark; Celina G Kleer; Iman Martin; Baffour Awuah; Anthony Nsiah-Asare; Valerie Takyi; Maria Braman; Solomon E Quayson; Richard Zarbo; Max Wicha; Lisa Newman Journal: Cancer Date: 2010-11-01 Impact factor: 6.860
Authors: Nathan S Consedine; Carol Magai; Yulia S Krivoshekova; Lynn Ryzewicz; Alfred I Neugut Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-04 Impact factor: 4.254
Authors: Louise A Brinton; Baffour Awuah; Joe Nat Clegg-Lamptey; Beatrice Wiafe-Addai; Daniel Ansong; Kofi M Nyarko; Seth Wiafe; Joel Yarney; Richard Biritwum; Michelle Brotzman; Andrew A Adjei; Ernest Adjei; Francis Aitpillah; Lawrence Edusei; Florence Dedey; Sarah J Nyante; Joseph Oppong; Ernest Osei-Bonsu; Nicholas Titiloye; Verna Vanderpuye; Emma Brew Abaidoo; Bernard Arhin; Isaac Boakye; Margaret Frempong; Naomi Ohene Oti; Victoria Okyne; Jonine D Figueroa Journal: Int J Cancer Date: 2017-03-28 Impact factor: 7.396
Authors: Louise Brinton; Jonine Figueroa; Ernest Adjei; Daniel Ansong; Richard Biritwum; Lawrence Edusei; Kofi M Nyarko; Seth Wiafe; Joel Yarney; Beatrice Wiafe Addai; Baffour Awuah; Joe Nat Clegg-Lamptey Journal: Breast Cancer Res Treat Date: 2016-12-26 Impact factor: 4.872
Authors: Christian Felix Reibold; Wakuma Tariku; Pia Eber-Schulz; Sefonias Getachew; Adamu Addisie; Susanne Unverzagt; Andreas Wienke; Steffen Hauptmann; Claudia Wickenhauser; Martina Vetter; Ahmedin Jemal; Christoph Thomssen; Eva Johanna Kantelhardt Journal: Breast Care (Basel) Date: 2021-01-15 Impact factor: 2.860
Authors: Darcy S Cherlin; Julius Mwaiselage; Khadija Msami; Zoe Heisler; Heather Young; Qingwei Cui; Amr S Soliman Journal: Biomed Res Int Date: 2022-04-05 Impact factor: 3.411